Skin Boosters: Do You Truly Know What This Treatment Entails?
What is a Skin Booster?
A skin booster is an injectable aesthetic treatment that directly delivers active ingredients, primarily hyaluronic acid (HA), into the dermal layer to improve the skin's moisture retention, elasticity, and surface texture. Rather than filling hollow areas or altering facial contours, its target is the intrinsic quality of the skin tissue itself (skin quality).
Internationally, they are classified as 'injectable skin boosters' or 'skin quality injectables.' In 2023, the U.S. FDA approved a low-concentration, minimally cross-linked hyaluronic acid formulation (VYC-12L) under a distinct category indicated for 'skin smoothness improvement' rather than volume augmentation. This demonstrates that 'skin booster' is not merely a marketing term, but an officially recognized procedural category acknowledged by regulatory authorities.
(Source: Next Steps in Dermatology, Injectable Skin Boosters: The Science Behind this New FDA-Approved Injectable Category)
How Do Skin Boosters Differ from Fillers?
The two procedures differ fundamentally in injection depth, formulation viscoelasticity, and intended clinical outcomes. Even when using the same active ingredient—hyaluronic acid—their engineering purposes differ, meaning they cannot substitute for one another.

Category | Skin Booster | Volume Filler |
|---|---|---|
Injection Depth | Mid-to-upper dermis, superficial subcutaneous layer | Deep subcutaneous layer, supra-periosteal layer |
Formulation Properties | Low viscoelasticity; minimal cross-linking or uncross-linked (free HA) | High viscoelasticity; highly cross-linked |
Primary Objective | Moisture retention, elasticity, skin texture, fine lines | Volume restoration, contour definition |
Diffusion Pattern | Spreads broadly across tissue | Maintains shape and remains anchored at injection site |
Treatment Protocol | Typically a series of 2–3 sessions at 2–4 week intervals | Single session followed by maintenance |
Nature of Expected Outcome | Gradual, tissue response-based regeneration | Immediate, physical space-occupying filling |
Summary: Fillers address 'shape and structure,' while skin boosters address 'skin condition and quality.'
Why Does Skin Thin and Develop Deep Dryness as We Age?
The root cause is not superficial dehydration on the surface, but the structural collapse of the dermis. With aging, collagen fibers within the dermis become fragmented, causing fibroblasts—which depend on mechanical tension from adhering to these fibers—to lose structural support and collapse.
According to the 'fibroblast collapse' concept established by researchers at the University of Michigan, fibroblasts that have lost mechanical tension reduce collagen synthesis while increasing the production of matrix metalloproteinases (MMPs), creating a vicious cycle that further thins the dermis. This underlying pathology is the reality behind what patients commonly describe as: "My skin feels tight and parched on the inside, no matter how much moisturizer I apply."
A skin booster is an approach designed to reintroduce physical mechanical tension and biological signaling into this compromised dermal microenvironment.
(Source: Looking Older: Fibroblast Collapse and Therapeutic Implications, Arch Dermatol / PMC2887041)
Is There International Research Evidence Proving That Skin Boosters Actually Work?
Yes. Substantial evidence has accumulated across progressive stages, ranging from histological mechanism studies to FDA-approved Phase 3 clinical trials. Key studies and quantitative results are summarized below:
Study (Source & Year) | Study Design | Subjects | Key Quantitative Results |
|---|---|---|---|
Wang et al., Archives of Dermatology (2007) | Forearm left-right controlled, histological biopsy | 11 photodamaged patients (mean age 74) | Type 1 procollagen gene expression increased ~10-fold at 4 weeks and ~18-fold at 13 weeks vs. control. Fibroblasts stretched into spindle shapes with increased rough endoplasmic reticulum. |
VYC-12L Phase 3 Trial (Basis for FDA Approval) | Multicenter, evaluator-blinded, randomized controlled trial | Adult subjects | Significant improvement in cheek smoothness from 1 to 6 months; improvements in fine lines and skin hydration. Hydration improvement was sustained up to 6 months. |
Hybrid Cooperative Complexes (HCC) Study, PLOS ONE (2016) | In vitro and 3D skin model | Human fibroblasts and keratinocytes | Within 24 hours, expression of Type 1 collagen increased ~7-fold, Type 3 collagen ~12-fold, and elastin ~12-fold compared to single-molecular-weight HA. After 10 days of hyaluronidase exposure, 35% of high-MW fraction remained (vs. <10% for linear HA). |
Open-Label Asian Clinical Study (2025) | Open-label, single-center trial | 30 female subjects (mean age 49.3) | At 12 weeks following 2 sessions (weeks 0 and 4): surface hydration increased by 21%, transepidermal water loss (TEWL) decreased by 21%, elasticity index (R3) significantly improved; no adverse events reported. |
In the above studies, the authors explained that hyaluronic acid integrates between fragmented collagen bundles, physically stretching and extending adjacent fibers. This mechanical tension reactivates fibroblasts via integrin receptors. In essence, these findings highlight that the primary therapeutic mechanism of skin boosters is closer to 'cellular reactivation' than merely 'water injection.'
Why Is the Molecular Weight of Hyaluronic Acid So Critical in Skin Boosters?
Because high-molecular-weight (HMW) and low-molecular-weight (LMW) hyaluronic acids perform distinct functions within the skin, and relying on either one alone is insufficient.
Category | High-Molecular-Weight HA (HMW-HA) | Low-Molecular-Weight HA (LMW-HA) |
|---|---|---|
Typical Molecular Weight | Approximately 1,000–1,500 kDa | Approximately 50–150 kDa |
Primary Actions | Water binding, dermal volume/mechanical tension creation, anti-inflammatory effect | CD44 and TLR receptor signaling, stimulation of fibroblast proliferation and migration |
Intra-tissue Behavior | High viscosity; remains relatively superficial and localized | Excellent diffusion; faster enzymatic degradation |
Limitations When Used Alone | Relatively weaker direct cellular signaling stimulation | Lacks structural mechanical support and longevity |
A 2016 study in PLOS ONE demonstrated that thermally conjugated complexes combining HMW (~1,200 kDa) and LMW (~100 kDa) hyaluronic acid in a 1:1 ratio without chemical cross-linking significantly boosted collagen and elastin expression compared to single-molecular-weight preparations. Following this research, 'molecular weight synergy' has become a foundational pillar in modern skin booster formulation design.
(Source: Hyaluronan Hybrid Cooperative Complexes as a Novel Frontier for Cellular Bioprocesses Re-Activation, PLOS ONE, 2016)
What Kind of Skin Booster is HILOWAVE?
Using HILOWAVE—a skin booster gaining significant recent attention—as an illustrative example: HILOWAVE is formulated with French-sourced, non-animal, high-purity hyaluronic acid featuring a dual-hybrid cooperative structure that bridges high- and low-molecular-weight HA. Manufactured by Higher Corporation, it was launched domestically in Korea in December 2024, with Neopharm overseeing domestic distribution starting in May 2025.

Item | Publicly Available Product Information |
|---|---|
Manufacturer / Domestic Distributor | Higher Corporation / Neopharm |
Raw Material | French non-animal, high-purity hyaluronic acid |
Molecular Structure | Dual-hybrid cooperative structure of High-MW + Low-MW hyaluronic acid |
HA Concentration | 24 mg/cc (per manufacturer disclosure; 2–3 times higher than conventional skin boosters) |
Cross-linking Agent | BDDE minimized |
Formulation Characteristics | Designed to spread extensively from deep to superficial dermal layers → Reduces required injection points |
Regulatory Approval (Korea) | Approved as a Class 4 medical device by the Ministry of Food and Drug Safety (MFDS) |
Target Treatment Areas | Cheeks, zygomatic arch, submalar area, nasolabial folds, perioral area, neck, etc. |
(Sources: BioTimes, Cosmorning, Medical Today)
What Are HILOWAVE's Distinctive Design Features in Light of Scientific Evidence?
Corresponding to the three research principles discussed earlier (molecular weight combination, physical mechanical tension, and procedural compliance), three primary characteristics can be identified:
1. Molecular Weight Combination Design — The dual-hybrid structure combining high- and low-molecular-weight HA aligns with the design paradigm established by the 2016 PLOS ONE HCC study. It is engineered with a synergistic division of labor: the high-MW fraction generates mechanical tension and retention in the dermis, while the low-MW fraction facilitates cellular signaling.
2. High Concentration + Low Cross-linking Formulation — A concentration of 24 mg/cc HA provides optimal conditions for exerting physical mechanical stretch. Simultaneously, minimizing BDDE cross-linking reduces the risk of foreign-body granulomatous reactions associated with residual cross-linkers. In the 'mechanical stretching → fibroblast reactivation' cascade demonstrated by Wang et al., an adequate HA payload is a critical determinant.
3. Reduced Injection Points via Enhanced Diffusion — This is not merely a matter of convenience. In clinical practice, the most common reason skin booster outcomes fall short of expectations is patient failure to complete the full 2–3 session series. The underlying deterrents are procedural pain, papules/embossing marks, bruising, and prolonged downtime. Reducing injection points lowers these procedural burdens and significantly increases protocol completion rates, directly benefiting final clinical outcomes.
Despite these multifaceted advantages, certain limitations must be kept in mind: the collagen and hydration figures cited in this article reflect broader international scientific literature on hyaluronic acid skin boosters as a class, rather than clinical trial data exclusive to HILOWAVE. Individual clinical outcomes will invariably vary depending on baseline skin condition, age, and personalized treatment plans.
How Many Sessions Are Needed, and at What Intervals?
Generally, a primary series of 2 to 3 sessions spaced 2 to 4 weeks apart is performed, followed by maintenance sessions considered at approximately 6-month intervals. The previously cited clinical study on Asian subjects was similarly structured with 2 treatments at weeks 0 and 4, followed by endpoint evaluation at week 12.
Stage | Timing | Clinical Objective |
|---|---|---|
1st Session | Week 0 | Initiation of moisture retention and dermal microenvironment remodeling |
2nd Session | 2–4 Weeks Later | Sustaining and accumulating biological tissue response |
3rd Session (Optional) | Additional 2–4 Weeks Later | Determined selectively based on individual skin response and condition |
Maintenance | Approximately Every 6 Months | Tailored individually according to ongoing skin assessment |
The onset and longevity of clinical effects exhibit individual variation, and every treatment regimen must be determined following medical consultation.
What Are the Potential Side Effects and Precautions After Skin Booster Treatments?
Common expected reactions include localized erythema (redness), mild edema (swelling), and bruising at injection sites, which typically resolve spontaneously within a few days. Rare complications may include nodules, localized infection, or hypersensitivity reactions.
Patients must inform their physician prior to treatment regarding any of the following:
· History of autoimmune disease or current use of immunosuppressive medications
· Current pregnancy or breastfeeding
· Current use of anticoagulants or antiplatelet agents (increased bruising risk)
· Known hypersensitivity or allergic history to hyaluronic acid, lidocaine, or local anesthetics
· Active infections, inflammatory acne flares, or acute dermatological conditions in the planned treatment area
Furthermore, without fundamental daily skincare maintenance—such as rigorous UV protection and appropriate topical retinoid use—the improvements achievable through skin boosters alone remain inherently limited.
Who Is an Ideal Candidate for Skin Boosters?
Skin boosters are ideal for individuals whose primary concerns center on dermal thinning, diminished elasticity, and impaired skin hydration. Conversely, if substantial volume loss or deep tissue sagging is the primary issue, other procedural modalities should be prioritized.
Skin Condition | Skin Booster Suitability | First-Line Alternative to Consider |
|---|---|---|
Deep dermal dryness, fine wrinkles, dull skin texture | Highly Suitable | — |
Thin skin feeling and reduced elasticity | Highly Suitable | Consider combining with energy-based devices (EBD) |
Volume loss in cheeks, temples, or submalar hollows | Unsuitable as monotherapy | Volume Fillers |
Prominent tissue sagging, compromised facial contour | Unsuitable as monotherapy | Lifting procedures (Thread, HIFU, RF) |
Active inflammatory acne, acute flare-up of rosacea | Timing must be deferred | Prioritize anti-inflammatory medical dermatological therapy |
Please consult with a board-certified dermatologist to determine exact medical indications. Selecting the optimal procedure tailored to each patient's specific skin profile, chief complaints, and indications is vital, as therapeutic outcomes will vary based on individual skin conditions.
Frequently Asked Questions (FAQ)
Procedural sequence and intervals must be adjusted according to individual skin condition. Same-day combination therapies are determined during clinical evaluation.
Q. Will the results of a skin booster be visible immediately after the procedure?
A. Initial hydration effects stemming from hyaluronic acid's water-binding capacity may be noticed relatively early. However, tissue remodeling involving collagen synthesis requires biological time. In the 2007 study by Wang et al., marked increases in Type 1 procollagen expression were objectively measured at 4 and 13 weeks. Outcomes vary individually.
Q. Does HILOWAVE create volume like a dermal filler?
A. HILOWAVE is categorized as a skin booster, not a volumizing filler. Its primary objective is improving skin hydration, elasticity, and texture, not altering facial contours. If volume restoration for hollow regions is desired, a separate procedural consultation for fillers is recommended.
Q. How long do the effects of a skin booster last?
A. Duration varies depending on the specific product and individual patient characteristics. In the Phase 3 trial for VYC-12L supporting FDA approval, improvements were observed up to 6 months. In typical clinical practice, maintenance sessions are considered roughly every 6 months following completion of the initial series. Longevity is influenced by age, baseline skin health, and lifestyle factors.
Q. Are products combining low and high molecular weights inherently superior?
A. In vitro and 3D skin model studies demonstrate that formulations combining high- and low-molecular-weight HA stimulated significantly higher collagen and elastin expression than single-MW preparations (PLOS ONE, 2016). However, these findings originate from laboratory model systems and should not be construed as guaranteeing absolute clinical superiority across all individual patients.
Q. When can I resume normal daily activities after the procedure?
A. As with any injectable procedure, localized redness or subtle injection marks may be present, which typically resolve within several hours to a few days. Recovery dynamics depend on the total number of injection points, treatment areas, and individual patient propensity for bruising.
References & Sources
• Wang F et al. In vivo stimulation of de novo collagen production caused by cross-linked hyaluronic acid dermal filler injections in photodamaged human skin. Archives of Dermatology. 2007. — View Original Paper
• Hyaluronan Hybrid Cooperative Complexes as a Novel Frontier for Cellular Bioprocesses Re-Activation. PLOS ONE. 2016;11(10):e0163510. — View Original Paper
• Efficacy and Tolerability of Stable Hybrid Cooperative Complexes of High- and Low-Molecular Weight Hyaluronic Acid in Asian Patients: An Open-Label Study. 2025. — View Original Paper
• Injectable Skin Boosters: The Science Behind this New FDA-Approved Injectable Category. Next Steps in Dermatology. — View Original Paper
• Looking Older: Fibroblast Collapse and Therapeutic Implications. Archives of Dermatology. — View Original Paper
• The Effectiveness of Injectable Hyaluronic Acid in the Improvement of the Facial Skin Quality: A Systematic Review. Clinical, Cosmetic and Investigational Dermatology. 2023. — View Original Paper
• Higher Corporation Launches 'HILOWAVE'. BioTimes. — View Article
• Neopharm Signs Exclusive Domestic Distribution Agreement for Skin Booster 'HILOWAVE'. Cosmorning. — View Article
• Dual Care for Inner Hydration and Elasticity: What Are the Key Considerations for 'HILOWAVE'? Medical Today. — View Article
Disclaimer
This medical column is intended solely for general informational purposes and does not constitute individual medical diagnosis, advice, or treatment recommendations. Quantitative figures cited reflect outcomes reported in specific published scientific studies and may not apply identically to all individual cases. Decisions regarding suitability and execution of any procedure should always be made following personalized consultation with a board-certified dermatologist.